MediRama

Resources

임상시험, 규제 전략, 혁신 항암제에 대한 컨퍼런스 및 웨비나 소식을 전해드립니다.

전체 16건

[MediRama EDGE] TUDRIQEV: from FDA CRLs to Accelerated Approval

2026.10.07

[MediRama EDGE] Vepdegestrant (Veppanu): The First FDA-Approved PROTAC-Clinical & Regulatory Insights

2026.08.27

[MediRama EDGE] A GR Antagonist, LIFYORLI™ (Relacorilant), in Ovarian Cancer: Redefining Chemotherapy Resistance

2026.05.26

[MediRama EDGE] BCMA BiTE (Teclistamab) deeper into multiple myeloma.

2026.03.27

[MediRama EDGE] When Companion Diagnostics Change: Assays, Cutoffs, Samples and Regulatory Inputs in Oncology Drug Development.

2026.03.03

[MediRama EDGE] A Review of Clinical Pharmacology Considerations in Antibody–Drug Conjugates Approved by the US Food and Drug Administration Between 2000 and 2025.

2026.01.29

[MediRama EDGE] Redefining Bladder Cancer Therapy The Anktiva BLA Story.

2025.04.24

[MediRama EDGE] Evolution of CD19 CAR-T in B-ALL: Why AUCATZYL Stands Out?

2025.03.27

[MediRama EDGE] Zanidatamab's Groundbreaking Approval Story in HER2-Positive BTC

2025.02.26

[MediRama EDGE] Vyloy for Gastric Cancer

2024.11.28

1
2